ARCHIVE OF ISSUES
Hospital Pharmacoeconomics
The quarterly journal published by Urtica is a valuable source of knowledge in the fields of pharmacoeconomics, pharmacotherapy and treatment safety. The content is based on the experience of researchers and specialists who are also practising professionals. The journal addresses issues relating to hospital pharmacy and the professional practice of hospital pharmacists. Below you will find a collection of the latest issues of our journal.
JUNE 2026
Issue 67
In this issue
This edition addresses topics of importance to hospital pharmacy, pharmacotherapy and medication safety, including the practical aspects of pharmacy compounding and medication management.
- Amendments to the 2025 Regulation of the Minister of Health – new challenges and obligations for pharmacies. Risk analysis as an assessment tool
- Compounded oral suspensions: a way to optimise treatment
- population pharmacokinetic modelling, i.e. the use of advanced mathematical models to optimise dosing in specific patient populations
- Cardiac complications of cancer treatment – from anthracyclines to immunotherapy. Cardiological follow-up in patients who have undergone cancer treatment
MARCH 2026
Issue 66
In this issue
This issue is devoted to topics of importance to the day-to-day practice of hospital pharmacy – ranging from the organisation of processes to clinical issues.
- management of the preparation of cytostatic drugs in a hospital pharmacy
- certification of contractors in public procurement
- an overview of new raw materials for pharmacy formulations
- technological support for the decomposition of solid oral dosage forms
DECEMBER 2025
Issue 65
In this issue
This issue focuses on therapeutic innovations and mechanisms for early access to medicines.
- accreditation standards for hospitals
- the role of the pharmacist in assessing interactions between medicines and enteral nutrition
- issues relating to the management of antibiotic therapy and the safety of treatment
- therapeutic innovations
JULY 2025
Issue 64
In this issue
This issue focuses on therapeutic innovations and the optimisation and safety of pharmacotherapy in hospital settings.
- optimisation of intravenous PPI therapy in hospital
- lecanemab – a substance recently authorised for marketing in Europe, which could represent a breakthrough in the treatment of Alzheimer’s disease
- pharmacy formulations for medicines used to treat proctological conditions
- the selection of NSAIDs and analgesics in the treatment of patients
APRIL 2025
Issue 63
- research and development of therapeutic compounds
- Drug interactions and the accumulation of adverse effects in clinical practice
- treatment of obesity with GLP-1 receptor agonists